Tiffany Schwasinger-Schmidt

Assistant Professor of Medicine

UNIVERSITY OF KANSAS SCHOOL OF MEDICINE

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tiffany Schwasinger-Schmidt is an Assistant Professor of Medicine at the University of Kansas School of Medicine Wichita, USA. Her research interests encompass clinical trials and patient outcomes, with recent articles focusing on amyotrophic lateral sclerosis, COVID-19 recovery protocols, and innovative recruitment strategies for dementia research. She has contributed to studies examining the efficacy of medications such as montelukast and fluvoxamine in various clinical contexts.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (2)

Omar Jawdat

University of Kansas Medical Center

UNITED STATES

View details

Zachary Simmons

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tiffany Schwasinger-Schmidt

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A service-oriented approach to clinical trial recruitment for dementia and brain health: Methods and case examples of MyAlliance for Brain Health

Effect of Montelukast vs Placebo on Time to Sustained Recovery in Outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.

Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.

A Piece of My Heart

Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19 The ACTIV-6 Randomized Clinical Trial

Prevalence of elevated alkaline phosphatase levels among post-bariatric surgery patients.

Discovery of New Transmitter Systems and Hence New Drug Targets.

Reverse Engineering Drugs: Lorcaserin as an Example.

Acceptability and Preliminary Effectiveness of a Remote Dementia Educational Training Among Primary Care Providers and Health Navigators.

Collaborators (2)

Omar Jawdat

Zachary Simmons

Make your next move.